Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Denise Risnik"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/8e513794719f4b6bb6a3fbcb017e4975
Autor:
Enrique Podaza, Florencia Palacios, Diego O. Croci, Denise Risnik, Xiao J. Yan, María Belén Almejún, Ana Colado, Esteban E. Elías, Mercedes Borge, Pablo E. Morande, Raimundo Bezares, Horacio Fernández-Grecco, Gabriel A. Rabinovich, Romina Gamberale, Nicholas Chiorazzi, Mirta Giordano
Publikováno v:
Haematologica, Vol 105, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/17a32b12fbca4ec28075f381b7ebcb97
Autor:
Esteban Enrique Elías, María Belén Almejún, Ana Colado, Gregorio Cordini, Maricef Vergara-Rubio, Enrique Podaza, Denise Risnik, María Cabrejo, Horacio Fernández-Grecco, Raimundo Fernando Bezares, María del Rosario Custidiano, Julio César Sánchez-Ávalos, Ángeles Vicente, Gonzalo Martín Garate, Mercedes Borge, Mirta Giordano, Romina Gamberale
Publikováno v:
Haematologica, Vol 103, Iss 10 (2018)
Externí odkaz:
https://doaj.org/article/e0976aeaa4804d988730be7196401a5c
Autor:
María Belén Almejún, Mercedes Borge, Ana Colado, Esteban Enrique Elías, Enrique Podaza, Denise Risnik, Carlos Daniel De Brasi, Carmen Stanganelli, Irma Slavutsky, María Cabrejo, Horacio Fernández-Grecco, Raimundo Fernando Bezares, Santiago Cranco, Rubén Ángel Burgos, Julio César Sánchez-Ávalos, Pablo Oppezzo, Mirta Giordano, Romina Gamberale
Publikováno v:
Haematologica, Vol 102, Iss 7 (2017)
Externí odkaz:
https://doaj.org/article/cad2ca19b2ef4fa7a94c5b4e68b9f5f9
Autor:
Lin Zhang, Jian Yu, Yi Huang, Hua Li, Peng Wang, Kaylee Ermine, Suisui Hao, Denise Risnik, Man Gao, Xiangping Song, Xiao Tan, Jingshan Tong
Targeting cyclin-dependent kinases 4 and 6 (CDK4/6) is a successful therapeutic approach against breast and other solid tumors. Inhibition of CDK4/6 halts cell cycle progression and promotes antitumor immunity. However, the mechanisms underlying the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f6e6ad8b88eac4b7a40100f306e78de
https://doi.org/10.1158/0008-5472.c.6513879.v1
https://doi.org/10.1158/0008-5472.c.6513879.v1
Autor:
Jingshan Tong, Xiao Tan, Xiangping Song, Man Gao, Denise Risnik, Suisui Hao, Kaylee Ermine, Peng Wang, Hua Li, Yi Huang, Jian Yu, Lin Zhang
Publikováno v:
Cancer Research. 82:1340-1352
Targeting cyclin-dependent kinases 4 and 6 (CDK4/6) is a successful therapeutic approach against breast and other solid tumors. Inhibition of CDK4/6 halts cell cycle progression and promotes antitumor immunity. However, the mechanisms underlying the
Autor:
Suisui Hao, Jingshan Tong, Anupma Jha, Denise Risnik, Darleny Lizardo, Xinyan Lu, Ajay Goel, Patricia L. Opresko, Jian Yu, Lin Zhang
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Synthetic lethality is a powerful approach for targeting oncogenic drivers in cancer. Recent studies revealed that cancer cells with microsatellite instability (MSI) require Werner (WRN) helicase for survival; however, the underlying mechanism remain
Autor:
Lin Zhang, Kaylee Ermine, Xiao Tan, Jingshan Tong, Shaomeng Wang, Man Gao, Denise Risnik, Liangfang Shen, Xiangping Song, Jian Yu
Publikováno v:
Oncogene. 40:6566-6578
Bromodomain and extra-terminal domain (BET) family proteins are epigenetic readers that play a critical role in oncogenesis by controlling the expression of oncogenes such as c-Myc. Targeting BET family proteins has recently emerged as a promising an
Autor:
Reet Pai, Lin Zhang, Yi-Jun Wang, Jian Yu, Robert L. Ferris, Jingshan Tong, Brian J. Leibowitz, Rochelle Fletcher, Donna B. Stolz, Robert E. Schoen, Denise Risnik, Fernando Concha-Benavente, Jonathan M. DeLiberty
Publikováno v:
Oncogene
Use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with reduced risk of colorectal cancer (CRC). However, the mechanism by which NSAIDs suppress colorectal tumorigenesis remains unclear. We previously showed that NSAIDs selectively k
Autor:
Mercedes Borge, Esteban Enrique Elías, Mirta Giordano, Ana Colado, Romina Gamberale, María Belén Almejún, Pablo Oppezzo, Horacio Fernández-Grecco, Enrique Podaza, Noé Seija, Denise Risnik, Raimundo F. Bezares
Publikováno v:
Cancer Immunology, Immunotherapy. 69:813-824
Despite significant therapeutic improvements chronic lymphocytic leukemia (CLL) remains an incurable disease and there is a persistent pursuit of new treatment alternatives. Lurbinectedin, a selective inhibitor of active transcription of protein-codi